Abrams Capital Management - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 144 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Abrams Capital Management ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$14,198,000
-81.5%
5,656,4620.0%0.45%
-81.9%
Q2 2020$76,815,000
+79.2%
5,656,4620.0%2.48%
+47.2%
Q1 2020$42,876,000
+19.9%
5,656,4620.0%1.69%
+51.8%
Q4 2019$35,749,000
+61.2%
5,656,4620.0%1.11%
+78.9%
Q3 2019$22,173,000
-19.0%
5,656,4620.0%0.62%
-16.5%
Q2 2019$27,377,000
-40.9%
5,656,4620.0%0.74%
-42.8%
Q1 2019$46,326,000
+48.1%
5,656,4620.0%1.30%
+0.6%
Q4 2018$31,280,000
+216.5%
5,656,462
+405.4%
1.29%
+395.4%
Q3 2018$9,883,0001,119,2860.26%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$1,471,0001.42%
Orchard Capital Management, LLC 251,826$80,0000.03%
GSA CAPITAL PARTNERS LLP 486,568$154,0000.02%
Icon Wealth Advisors, LLC 400,132$1270.02%
ACADIAN ASSET MANAGEMENT LLC 7,483,053$2,365,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,042,816$646,0000.01%
WIPFLI FINANCIAL ADVISORS LLC, 200,000$63,0000.00%
WEALTH EFFECTS LLC 18,316$6,0000.00%
James J. Burns & Company, LLC 25,142$8,0000.00%
Bayesian Capital Management, LP 68,600$22,0000.00%
View complete list of AKEBIA THERAPEUTICS INC shareholders